Related Experiment Videos
Extracorporeal life support for pediatric respiratory failure
F W Moler1, J R Custer, R H Bartlett
1Department of Pediatrics, University of Michigan Hospitals, Ann Arbor.
Critical Care Medicine
|August 1, 1992
Summary
Extracorporeal life support (ELS) offers a 60% survival rate for pediatric patients with severe respiratory failure. This study highlights ELS as an effective rescue therapy, identifying key factors associated with survival in young patients.
Area of Science:
- Pediatric critical care medicine
- Cardiopulmonary support technologies
- Respiratory failure management
Background:
- Severe respiratory failure in children presents a significant therapeutic challenge.
- Extracorporeal life support (ELS) provides temporary cardiopulmonary support.
- Understanding outcomes and predictors of survival in pediatric ELS is crucial.
Purpose of the Study:
- To describe the University of Michigan's experience with extracorporeal life support (venoarterial or venovenous) for pediatric respiratory rescue.
- To identify differences between survivors and nonsurvivors to inform future research.
Main Methods:
- A case series of non-neonatal pediatric patients treated with ELS for severe respiratory failure.
- Data collected included patient demographics, mechanical ventilation parameters, and blood gas values.
- Survival rates and factors associated with survival were analyzed.
Main Results:
- A 60% survival rate (15/25 patients) was achieved for pediatric patients undergoing ELS.
- Younger age and lower mechanical ventilation pressures (peak inspiratory, mean airway, PEEP) were associated with survival.
- No significant differences in pre-ELS blood gas values were found between survivors and nonsurvivors.
Conclusions:
- Extracorporeal life support is an effective rescue therapy for pediatric severe respiratory failure.
- The University of Michigan reported a 60% survival rate, demonstrating the efficacy of ELS.
- Further prospective studies are warranted to confirm predictors of survival.